FLEX vs PFE · P/E 23, rev $6.40B vs P/E 20, rev $62.58B
Flex Ltd (FLEX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the FLEX and PFE stock pages for the full models.
Not investment advice.